Here is a recently published report regarding Locteron, a new, slow release interferon administered every two weeks. What looks really promising is that the side effect profile in this study looks much more 'user friendly' than currently used peg-interferons and infergen. Also, the other highly positive finding is that this new interferon seems to be even more effective in achieving complete response within twelve weeks. They had 100% with a minimum 2-log drop, and it seems most had a 4-log drop over twelve weeks, as compared to lower numbers for the currunt drugs.
Using these newer, less intrusive, less 'painful' interferons, if and when they are approved should provide a great cocktail partner to the newer protease and polymerase inhibitor drugs in trials.
Conceivably, in the not too distant future, one might combine a solid protease inhibitor, a safe, effective polymerase inhibitor, and the newer milder long acting interferon, along with Ribavirin, and maybe even the really tough cases go for about twelve weeks maximum. Let's all hope this is where things are heading. Lots of great progress out there!
Here is the link:
http://www.hivandhepatitis.com/2007icr/aasld/docs/113007_d.html
DoubleDose